Cited by 115Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsNeurological Disease Mechanisms and Treatments

Monomeric C-reactive protein-a key molecule driving development of Alzheimer’s disease associated with brain ischaemia?

Open access
Slevin, M., Matou, S., Zeinolabediny, Y., Corpas, R., Weston, R., Liu, D., Boras, E., Di Napoli, M. +11 more·2015·Scientific Reports

Abstract

Alzheimer’s disease (AD) increases dramatically in patients with ischaemic stroke. Monomeric C-reactive protein (mCRP) appears in the ECM of ischaemic tissue after stroke, associating with microvasculature, neurons and AD-plaques, Aβ, also, being able to dissociate native-CRP into inflammatory, mCRP in vivo. Here, mCRP injected into the hippocampal region of mice was retained within the retrosplenial tract of the dorsal 3rd ventrical and surrounding major vessels. Mice developed behavioural/cognitive deficits within 1 month, concomitant with mCRP staining within abnormal looking neurons expressing p-tau and in beta-amyloid 1-42-plaque positive regions. mCRP co-localised with CD105 in microvessels suggesting angiogenesis. Phospho-arrays/Western blotting identified signalling activation in endothelial cells and neurons through p-IRS-1, p-Tau and p-ERK1/2-which was blocked following pre-incubation with mCRP-antibody. mCRP increased vascular monolayer permeability and gap junctions, increased NCAM expression and produced haemorrhagic angiogenesis in mouse matrigel implants. mCRP induced tau244–372 aggregation and assembly in vitro. IHC study of human AD/stroke patients revealed co-localization of mCRP with Aβ plaques, tau-like fibrils and IRS-1/P-Tau positive neurons and high mCRP-levels spreading from infarcted core regions matched reduced expression of Aβ/Tau. mCRP may be responsible for promoting dementia after ischaemia and mCRP clearance could inform therapeutic avenues to reduce the risk of future dementia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep13281

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Monomeric CRP acts as a linker between vascular trauma and inflammation and is associated with plaque generation, neuronal injury, and dementia.

    “Monomeric CRP acts as a linker between vascular trauma and inflammation and also is associated with other events like plaque generation, neuronal injury, and dementia [52].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 51 · Cited by 115

Research works printed but not linked: 5

  1. Garcia-Mesa Y.. Physical exercise protects against Alzheimer’s disease in 3xTg-AD mice. J. Alzheimer’s Dis. 24, 421– 454 (2011). 21297257
  2. Balczon R.. Pseudomonas aeruginosa exotoxin Y-mediated tau hyperphosphorylation impairs microtubule assembly in pulmonary microvascular endothelial cells. PLoS One. 8, e74343 (2013). 24023939 PMC3762819
  3. Rajas J.. Enhanced Aβ(1-40) production in endothelial cells stimulated with fibrillar Aβ(1-42). PLoS One. 8, e58194 (2013). 23505467 PMC3591408
  4. Mirra S. S.. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology. 41, 479– 486 (1991). 2011243
  5. Braak H., Alafuzoff I., Arzberger T., Kretzschmar H. & Del Tredici K. Staging of Alzheimer’s disease-associated neurofibrillary pathologyusing paraffin sectionsand immunohistochemistry. Neuropathol. 112, 389– 404 (1996). PMC3906709 16906426

Authors
Slevin, M., Matou, S., Zeinolabediny, Y., Corpas, R., Weston, R., Liu, D., Boras, E., Di Napoli, M., Petcu, E., Sarroca, S., Popa-Wagner, A., Love, S., Font, M. A., Potempa, L. A., Al-baradie, R., Sanfeliu, C., Revilla, S., Badimon, L., & Krupinski, J.
Affiliations
  • Griffith University (AU)
  • Manchester Metropolitan University (GB)
  • Consejo Superior de Investigaciones Científicas (ES)
  • University of Bristol (GB)
  • Majmaah University (SA)
Corresponding author
Slevin, M.
Venue
Scientific Reports
Published
2015-09-03
Volume
5
Issue
1
Pages
13281-13281
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2208874007
Cited by
115
References
51
Citations by year
2026: 3 · 2025: 8 · 2024: 14 · 2023: 10 · 2022: 16 · 2021: 24 · 2020: 10 · 2019: 5 · 2018: 14 · 2017: 4 · 2016: 7
FWCI
6.14
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • e-space (Manchester Metropolitan University) (acceptedVersion)
  • Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
  • Griffith Research Online (submittedVersion, cc-by)
Funders
Banco Bilbao Vizcaya Argentaria
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
monomeric C-reactive protein, Alzheimer's disease, ischemic stroke, brain ischaemia, tau aggregation, amyloid plaques, tau phosphorylation, ERK signaling, angiogenesis, endothelial permeability, gap junctions, CD56, dementia, hippocampus, CD105
MeSH terms
Alzheimer Disease, Animals, Brain Ischemia, Male, Mice, Inbred C57BL, Neurons, Receptors, Immunologic, Biomarkers, Disease Progression, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review